Leerink Partners Reiterates Outperform Rating on Aurinia Pharmaceuticals (AUPH)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: AUPH) | Delayed: 16.65 -0.56 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.21 | 52 Week High | $5.69 | |||
| Open | $16.76 | 52 Week Low | $1.42 | |||
| Day High | $17.04 | P/E | N/A | |||
| Day Low | $16.48 | EPS | $0.00 | |||
| Volume | 960,844 | |||||
